Lanchi & Legend Join Gaorong in Immunotherapies
28 Nov 2024
US$ 19.00
Lanchi Ventures has led the US$42 million series A funding round of Shanghai Allink Biotherapeutics Co Ltd (Allink) ......
Related Publications
Subscribers’ Weekly for the week ending 29th November 2024...
APER Dec 2024 - India in Quotes...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.